Add To Watchlist
Share URL
About The Company
CEO
Mr. Robert M. Davis J.D.
Market Cap
322.68 Billion USD
Sector
Healthcare
Website
https://www.merck.comLast Update
2/22/2024, 12:00:00 PM
Description
Merck & Co., Inc.
Read More
Overview
Value
26
Growth
70
Health
54
Management
55
Analyst Opinion
71
Total
55
All Scores Out Of 100
Best Features
- Very strong cashflow and earnings growth
- Has a low level of debt
- Has a history of share buybacks
- Low risk of bankruptcy
- Liked by analysts
- Has strong dividend growth
Risk Factors
- Earnings have declined recently
- Disliked by Twitter users
- Price-to-earnings ratio of 818.9 is higher than the market average (19.6x)
- High preportion of income is paid as dividend
Market Peers
MRK
Key Figures
PE Ratio (TTM)
818.87
Margin Of Safety (DCF)
38.74%
Revenue Growth (5 Year Average)
8.08%
Ratings Consensus
Buy
Share Buybacks
1.25%
Dividend Yeild (TTM)
2.39%
Valuation
Value Score
26
- ✔ Margin-of-safety of 38.74% is better than the market average (17.95%)
- ✔ Estimated intrinsic-value of 170.41 USD is higher than current price ( 127.41 USD)
- ✘ Price-to-earnings ratio of 818.9 is higher than the market average (19.6x)
- ✘ Free-cashflow-yeild of 2.94% is worse than the market average (4.7%)
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: < 108.3 USD ✘
Current Price: 122.8 USD
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
818.87x
Free Cashflow Yeild
2.94%
PE/Earnings Growth
73.71
Price/Book
8.27x
Growth
Growth Score
70
- ✔ 5 Year Average Earnings growth of 24.53% is higher than the market average (14.48%)
- ✔ 5 Year Average Cashflow growth of 23.49% is higher than the market average (12.35%)
- ✘ 5 Year Average Revenue growth of 8.08% is lower than the market average (10.97%)
- ✘ Revenue growth has slowed this year
- ✘ Earnings growth has slowed this year
- ✘ Free Cashflow growth has slowed this year
Revenue Growth
8.08%
Earnings Growth
24.53%
Cashflow Growth
23.49%
Health
Health Score
54
Altman Z Score
4.12
Piostroski Score
7.00
Debt/Equity
0.67x
Current Assets/Liabilities
1.47x
Free Cashflow/Total Debt
0.48x
Debt/Capital
0.86x
Dividend
Secure Dividend Score
37
- ✔ Dividend yeild of 2.39% is more than the market average (1.85%)
- ✘ At risk of being unsafe
- ✔ Dividends have shown growth over the last 5 years
- ✘ Long term dividend payout ratio of 90.62% is high and may limit growth
- ✘ Payout ratio (TTM) of 2039.73% is higher than the average (40%)
- ✘ Dividend growth has been slowing recently
- ✘ Spending a higher percentage of their income on dividends than last 5 years
Dividend Yeild
2.39%
Dividend Growth
6.08%
Payout Ratio (Earnings)
2039.73%
Payout Ratio (Cashflow)
81.43%
Management
Management Score
55
- ✔ Has a history of returning value to shareholders through stock buybacks
- ✔ Has returned higher dividends when earnings have risen
- ✔ Return-on-equity of 31.55% is higher than the market average (15%)
- ✔ Return-on-capital-employed of 12.32% is higher than the market average (10%)
- ✘ Has repurchased shares when overvalued
Average Buybacks/Dilution
1.25%
Recent Buybacks/Dilution
0.03%
5 Year Price Volitility
14.29%
Return On Assets
13.29%
Return On Capital Employed
12.32%
Return On Equity
31.55%
Return On Free Cashflow
N/A
Return On Investments
959.16%
Analysts
Analyst Opinion
71
- ✔ Ratings consensus is Buy
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
Merck & Co., Inc.
Currency
USD
Beta
0.352459
Vol Avg
7131183
Ceo
Mr. Robert M. Davis J.D.
Cik
0000310158
Cusip
58933Y105
Exchange
New York Stock Exchange
Full Time Employees
67000
Industry
Drug Manufacturers—General
Sector
Healthcare
Ipo Date
1962-01-02
Address
2000 Galloping Hill Road
City
Kenilworth
State
NJ
Country
US
Zip
07033
Phone
908 740 4000
Analysis Last Updated
2/22/2024, 12:00:00 PM
All financial data provided by FMP
Social Sentiment
Social Sentiment Score
0
Twitter Sentiment
N/A
Stocktwits Sentiment
N/A